New Approaches to Vaccine Development and Delivery—2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Design, Development, and Delivery".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 103
Special Issue Editors
Interests: molecular biology of papillomavirus infections; development of vaccination strategies; control of papilomaviroses and associated diseases
Special Issues, Collections and Topics in MDPI journals
Interests: oncogenes cancer research; immunology; cell biology; HPV
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent breakthroughs in immunology, protein engineering and genetic delivery have opened doors to innovative vaccine approaches that were once unattainable. These advanced designs demonstrate potential for targets where traditional methods have been ineffective. Modern strategies, including nucleic acid vaccines, whole-cell vaccines, novel delivery techniques and shelf-stable formulations, are paving new paths in both preventive and therapeutic vaccines. In this Special Issue, we will examine recent developments in vaccine technologies and delivery systems that could expand the field's possibilities.
Dr. Antonio Carlos de Freitas
Dr. Anna Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines and delivery
- vaccine formulation
- vaccine delivery systems
- adjuvants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- New Approaches to Vaccine Development and Delivery in Vaccines (5 articles)
